Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (688212) — Capital Reinvestment Ratio

Latest as of December 2023: 4.22x

Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (688212) has a Capital Reinvestment Ratio of 4.22x as of December 2023, meaning it reinvests 4% of its operating cash flow (CN¥37.41 Million) in capital expenditures (CN¥157.83 Million). Check tangible net worth ratio of Shanghai Aohua Photoelectricity Endoscop to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

4.22x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥37.41 Million
CNY

Capital Expenditures

CN¥157.83 Million
CNY

Data as of

Dec 2023
Most recent filing

Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A Capital Reinvestment Ratio (2019–2023)

This chart tracks Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see Shanghai Aohua Photoelectricity Endoscop (688212) cash conversion ratio.

Annual Capital Reinvestment Ratio for Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (2019–2023)

Year-by-year Capital Reinvestment Ratio for Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A from 2019 to 2023. See 688212 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2023 4.22x CN¥37.41 Million CN¥157.83 Million ▲ +204.7%
2021 1.38x CN¥66.15 Million CN¥91.61 Million ▲ +60.2%
2020 0.86x CN¥71.52 Million CN¥61.83 Million ▼ -37.4%
2019 1.38x CN¥47.39 Million CN¥65.50 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow